Pereira L, da Silva M, Germano C, Estevao I, Melo D
Front Med (Lausanne). 2023; 10:1144226.
PMID: 37200963
PMC: 10187638.
DOI: 10.3389/fmed.2023.1144226.
Madany E, Okwan-Duodu D, Balbuena-Merle R, Hendrickson J, Gibb D
Front Med (Lausanne). 2021; 8:679030.
PMID: 34368185
PMC: 8339405.
DOI: 10.3389/fmed.2021.679030.
Tremblay D, Rapp J, Alpert N, Lieberman-Cribbin W, Mascarenhas J, Taioli E
EJHaem. 2021; 2(3):319-326.
PMID: 34226904
PMC: 8242891.
DOI: 10.1002/jha2.167.
Anusim N, Gupta R, Ahaneku H, Franklin C, Balaraman S, Huben M
EJHaem. 2021; 2(1):124-127.
PMID: 33821259
PMC: 8014642.
DOI: 10.1002/jha2.162.
Walker S, Murphy M, Hendricks H, Dulek D, Volanakis E, Borinstein S
Clin Case Rep. 2021; 9(3):1367-1370.
PMID: 33768846
PMC: 7981740.
DOI: 10.1002/ccr3.3774.
Management of Sickle Cell Disease Complications Beyond Acute Chest Syndrome.
Ogu U, Badamosi N, Camacho P, Freire A, Adams-Graves P
J Blood Med. 2021; 12:101-114.
PMID: 33658881
PMC: 7920619.
DOI: 10.2147/JBM.S291394.
Simultaneous diagnosis of severe SARS-CoV-2 infection and sickle cell disease in two infants.
Parodi E, Voi V, Vania B, Lonardi P, Saracco P, Longobardo A
Blood Transfus. 2021; 19(2):120-123.
PMID: 33539288
PMC: 7925224.
DOI: 10.2450/2021.0430-20.
Current Perspectives of convalescent plasma therapy in COVID-19.
Sahu K, Mishra A, Raturi M, Lal A
Acta Biomed. 2021; 91(4):e2020175.
PMID: 33525227
PMC: 7927533.
DOI: 10.23750/abm.v91i4.10681.
COVID-19 in patients with sickle cell disease: A single center experience from Ohio, United States.
Sahu K, George L, Jones N, Mangla A
J Med Virol. 2021; 93(5):2591-2594.
PMID: 33480063
PMC: 8014569.
DOI: 10.1002/jmv.26816.
Hemoglobinopathy and pediatrics in the time of COVID-19.
Vilela T, Braga J, Loggetto S
Hematol Transfus Cell Ther. 2020; 43(1):87-100.
PMID: 33289008
PMC: 7709722.
DOI: 10.1016/j.htct.2020.11.002.
A review on how to do hematology consults during COVID-19 pandemic.
Sahu K, cerny J
Blood Rev. 2020; 47:100777.
PMID: 33199084
PMC: 7648889.
DOI: 10.1016/j.blre.2020.100777.
COVID-19 Pandemic and Children: A Review.
Rathore V, Galhotra A, Pal R, Sahu K
J Pediatr Pharmacol Ther. 2020; 25(7):574-585.
PMID: 33041712
PMC: 7541032.
DOI: 10.5863/1551-6776-25.7.574.
COVID-19 and sickle cell disease in Bahrain.
Abdulrahman A, AlAli S, Yaghi O, Shabaan M, Otoom S, Atkin S
Int J Infect Dis. 2020; 101:14-16.
PMID: 32980556
PMC: 7833176.
DOI: 10.1016/j.ijid.2020.09.1433.
Mesenchymal Stem Cells in COVID-19: A Journey from Bench to Bedside.
Sahu K, Siddiqui A, cerny J
Lab Med. 2020; 52(1):24-35.
PMID: 32729620
PMC: 7454767.
DOI: 10.1093/labmed/lmaa049.
Varying presentations and favourable outcomes of COVID-19 infection in children and young adults with sickle cell disease: an additional case series with comparisons to published cases.
Appiah-Kubi A, Acharya S, Fein Levy C, Vlachos A, Ostovar G, Murphy K
Br J Haematol. 2020; 190(4):e221-e224.
PMID: 32652551
PMC: 7405127.
DOI: 10.1111/bjh.17013.
Challenges for management of immune thrombocytopenia during COVID-19 pandemic.
Sahu K, Siddiqui A, Rezaei N, cerny J
J Med Virol. 2020; 92(11):2277-2282.
PMID: 32619062
PMC: 7361579.
DOI: 10.1002/jmv.26251.
Trajectory of the COVID-19 pandemic: chasing a moving target.
Sahu K, Mishra A, Lal A
Ann Transl Med. 2020; 8(11):694.
PMID: 32617314
PMC: 7327313.
DOI: 10.21037/atm-20-2793.